Viewing StudyNCT03215277



Ignite Creation Date: 2024-05-06 @ 10:17 AM
Last Modification Date: 2024-10-26 @ 12:27 PM
Study NCT ID: NCT03215277
Status: COMPLETED
Last Update Posted: 2023-07-27
First Post: 2017-07-05

Brief Title: A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis
Sponsor:
Organization: UCB Pharma